Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Geographic location of antineoplastic agent clinical trials conducted in developed and developing countries.

Lu F, Suda KJ, Marks KE.

Int J Clin Pharm. 2013 Feb;35(1):87-91. doi: 10.1007/s11096-012-9711-6. Epub 2012 Oct 10.

PMID:
23054141
2.

Published pediatric randomized drug trials in developing countries, 1996-2002.

Nor Aripin KN, Sammons HM, Choonara I.

Paediatr Drugs. 2010 Apr 1;12(2):99-103. doi: 10.2165/11316260-000000000-00000.

PMID:
20218746
3.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
4.

Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.

Khin NA, Chen YF, Yang Y, Yang P, Laughren TP.

J Clin Psychiatry. 2011 Apr;72(4):464-72. doi: 10.4088/JCP.10m06191. Erratum in: J Clin Psychiatry. 2011 Jun;72(6):874.

PMID:
21527123
5.

Geographic location of antiretroviral clinical trials in HIV infected pediatric patients.

Suda KJ, Greene J, Shelton CM.

Int J Clin Pharm. 2013 Dec;35(6):1203-7. doi: 10.1007/s11096-013-9849-x. Epub 2013 Sep 19.

PMID:
24048618
6.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900
7.

Impact of Geographic Region on Benefit of Approved Anticancer Drugs Evaluated in International Phase III Clinical Trials.

AlHashem HY, Al-Mubarak M, Vera-Badillo FE, Templeton AJ, Ocana A, Seruga B, Amir E.

Clin Oncol (R Coll Radiol). 2016 May;28(5):283-91. doi: 10.1016/j.clon.2015.09.010. Epub 2015 Nov 2.

PMID:
26542275
8.

Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration.

Khin NA, Chen YF, Yang Y, Yang P, Laughren TP.

J Clin Psychiatry. 2012 Jun;73(6):856-64. doi: 10.4088/JCP.11r07539. Epub 2012 May 15. Review.

PMID:
22687813
9.

Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.

Adis International Ltd.

Drugs R D. 2003;4(4):243-8.

PMID:
12848590
10.

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.

11.

Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.

Pienaar ED, Young T, Holmes H.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD003940. doi: 10.1002/14651858.CD003940.pub3. Review.

PMID:
21069679
12.

Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).

Brettschneider C, Lühmann D, Raspe H.

GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092.

13.

Association of trial registration with the results and conclusions of published trials of new oncology drugs.

Rasmussen N, Lee K, Bero L.

Trials. 2009 Dec 16;10:116. doi: 10.1186/1745-6215-10-116.

14.

A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.

Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C.

Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. Review.

15.

Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region.

Augustovski F, Iglesias C, Manca A, Drummond M, Rubinstein A, Martí SG.

Pharmacoeconomics. 2009;27(11):919-29. doi: 10.2165/11313670-000000000-00000. Review.

PMID:
19888792
16.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001747.

PMID:
11687119
17.

Optimal duration of exclusive breastfeeding.

Kramer MS, Kakuma R.

Cochrane Database Syst Rev. 2002;(1):CD003517. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD003517.

PMID:
11869667
18.

Population-based interventions for reducing sexually transmitted infections, including HIV infection.

Sangani P, Rutherford G, Wilkinson D.

Cochrane Database Syst Rev. 2004;(2):CD001220. Review. Update in: Cochrane Database Syst Rev. 2011;(3):CD001220.

PMID:
15106156
19.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(1):CD001747. Review. Update in: Cochrane Database Syst Rev. 2001;(4):CD001747.

PMID:
11279727
20.

Handsearching versus electronic searching to identify reports of randomized trials.

Hopewell S, Clarke M, Lefebvre C, Scherer R.

Cochrane Database Syst Rev. 2007 Apr 18;(2):MR000001. Review.

PMID:
17443625

Supplemental Content

Support Center